An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens…
The Morrison Government’s Biomedical Translation Fund (BTF) is investing $20 million in Australian biotech start-up George Medicines to develop new medications for the prevention of heart attacks and strokes, as well as treatments for a range of chronic conditions such as high blood pressure, hypertension and diabetes. The funding comprises $10 million from the Government…
The Morrison Government is continuing to drive investment in early stage companies and innovations that can grow the economy and create new Australian jobs. New ABS figures show total venture capital investment soared from $574 million in 2017-18 to $701 million last financial year – the highest level since 2007-08, and up from less than…
$14 million will be provided for a pioneering project to prevent severe oral disease through the Morrison Government-backed Biomedical Translation Fund (BTF). Denteric Pty Ltd is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three…